Navigation Links
Shionogi Inc. Announces Commercial Availability of KAPVAY™ (clonidine hydrochloride) Extended-Release Tablets for the Treatment of ADHD
Date:1/10/2011

excreted in human milk, caution should be exercised when KAPVAY™ is administered to a nursing woman.

Caution is warranted in patients receiving clonidine concomitantly with agents known to affect sinus node function or AV nodal conduction (e.g., digitalis, calcium channel blockers and beta-blockers) due to a potential for additive effects such as bradycardia and AV block.

Clonidine, the active ingredient in KAPVAY™, is also approved as an antihypertensive.  Do not use KAPVAY™ in patients concomitantly taking other clonidine-containing products, (e.g. Catapres®, JENLOGA, etc.).

Common adverse reactions (incidence at least 5% and twice the rate of placebo) include:

Somnolence, fatigue, upper respiratory tract infection, irritability, throat pain, insomnia, nightmares, emotional disorder, constipation, nasal congestion, increased body temperature, dry mouth, and ear pain.

To report SUSPECTED ADVERSE REACTIONS, contact Shionogi Pharma, Inc. at 1-800-849-9707 ext. 1454 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

For full prescribing information, please visit www.KAPVAY.com.  

About ADHD

ADHD is a neurobehavioral disorder that most often occurs in childhood and may continue into adolescence and adulthood. There are three subtypes of ADHD: predominantly hyperactive-impulsive, predominantly inattentive, and combined hyperactive-impulsive and inattentive, with the latter being the most common. ADHD symptoms fall under three main categories: inattention, hyperactivity and impulsivity, which can include behaviors such as trouble focusing, frequent daydreaming, excessive talking, fidgeting/squirming, chronic impatience and difficulty waiting their turn, depending on the category.

The cause of ADHD is not yet known. However, research has shown potential links to genetic and environmental fac
'/>"/>

SOURCE Shionogi Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
2. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
3. BioCrysts Partner Shionogi Launches Peramivir In Japan Under The Name RAPIACTA
4. Shionogi Enters Into Exclusive License Agreement With QuatRx Pharmaceuticals To Market Ospemifene
5. Shionogi Inc. Announces FDA Approval of CUVPOSA™ for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions
6. Shionogi-ViiV Healthcare LLC Initiates Phase III Clinical Programme for Investigational Once-Daily HIV Integrase Inhibitor
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... LA JOLLA, Calif. , Nov. 26, 2014 /PRNewswire/ ... ), a biopharmaceutical company leading the discovery and development ... Kleanthis G. Xanthopoulos , Ph.D., President and CEO of ... th Annual Piper Jaffray Healthcare Conference at the ... at 2:00 p.m. EST.  The presentation will be webcast ...
(Date:11/26/2014)... Scott Steiger lives in St. Louis ... for the past 20 years, he,s traveled extensively and prior to ... to six of the seven continents. Travel is a big part ... Photo - http://photos.prnewswire.com/prnh/20141126/161077 So when he ... idea of what,s required. His latest creation is the ...
(Date:11/26/2014)... -- CARsgen, a leader in the development of Chimeric Antigen ... of cancers, today announced the completion of a series ... -based healthcare private equity fund.   ... of new therapeutics for liver, lung, stomach and brain ... Renji Hospital, the company plans to initiate clinical studies ...
Breaking Medicine Technology:Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 2Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 3Steiger Has Created the First Pill Case Specifically Designed For Travel 2CARsgen Completes Series A Financing 2
... Dermatologist Promoting Regular Skin Examinations, SAN DIEGO, ... resident is diagnosed with a new case of ... A local dermatologist is working,to decrease this alarming ... with this deadliest type of skin cancer will ...
... treatment of Gaucher Disease, CARMIEL, Israel, Aug. 27 ... that it has treated the,first patient in its phase ... a proprietary plant cell expressed recombinant form of,human Glucocerebrosidase ... disorder in humans. The phase III clinical trial ...
Cached Medicine Technology:Saving Lives of California Residents Who Develop Skin Cancer Each Year: The Key is Early Detection and Treatment 2Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD 2Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD 3
(Date:11/27/2014)... Two international trainers and lecturers on the ... one person with significant needs but limited means obtain ... Mamaly Reshad of the Anacapa Dental Art Institute in ... devoted to helping dentist learn about using All-on-4™ dental ... devoted to helping a patient who has damaged or ...
(Date:11/27/2014)... “LAB.C” was featured on NewsWatch as part ... coolest technology products available to consumers. Mallory Sofastaii, a technology ... and shared with viewers the company offers a cable ... , Consumers love portability and functionality. A unique mobile ... the iPhone5 and 5S has a portable USB charger built ...
(Date:11/27/2014)... Texas (PRWEB) November 27, 2014 ... report on Global Insulin industry. For an overview ... definition, classification, application, industry chain structure, industry overview, ... on global Insulin industry covers information on ... process, product cost structure and much more. ...
(Date:11/27/2014)... 27, 2014 Allowing children to help with ... school, helps give children responsibility, ownership, boosts self-esteem, and above ... , Now, the real question is, how do you encourage ... According to a study published by Child Development Journal, there ... dramatic effect on a child’s willingness to lend a hand. ...
(Date:11/27/2014)... 27, 2014 RBSEO Services, a ... engine optimization service just at $99. RBSEO Services ... cannot afford costly search engine optimization service. So, ... their affordablity and requirements into consideration. , ... it has not compromised with the service quality. ...
Breaking Medicine News(10 mins):Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 2Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 3Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 4Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 5Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 3Health News:RBSEO Services Announces SEO Services at $99 Only 2
... McClellan to Give Keynote Speech, WASHINGTON, June ... molecular machinery is pointing toward new drugs and,treatments ... emerging,era of health care, called personalized medicine, also ... and industry,marketing strategies., To help the food ...
... New West,s Ability to Provide Outstanding ... Healthcare Service and Access, ... PER ) and New West Health Services -- Montana,s second,largest ... Systems will host New West,s enterprise core administrative,system (CAS), and ...
... (St. Mary,s City, MD) June 12, 2008Encore Creativity for ... will co-host Encore,s first Summer Chorale Camp Tuesday, June ... executive director Jeanne Kelly helped lead a study about ... between regular artistic activity and improved physical and mental ...
... Ovarian function can be preserved and disease activity controlled ... treated with a 6-month course of cyclophosphamide (CYC), a ... according to a new study presented today at EULAR ... Rheumatism in Paris, France. , SLE, a complex ...
... Standards and Technology (NIST) have developed a simplified, ... for biological research. By using a laboratory microwave ... used nanomaterials, the recently published* NIST process avoids ... making quantum dots, resulting in brighter, more stable ...
... a stroke, even unaffected areas of the brain are at ... dead tissue and spread through the adjacent areas of the ... has previously been observed only in animal studies. , A ... along with the Max Planck Institute of Neurological Research in ...
Cached Medicine News:Health News:FDLI, AAAS Host June 20 Conference on Personalized Medicine 2Health News:FDLI, AAAS Host June 20 Conference on Personalized Medicine 3Health News:New West Health Services Selects Perot Systems Xcelys(TM) 5.0 Software 2Health News:New West Health Services Selects Perot Systems Xcelys(TM) 5.0 Software 3Health News:NIH study concludes next week's summer chorus camp for seniors improves quality of life 2Health News:Ovarian function and fertility preserved in women with severe systemic lupus erythematosus 2Health News:Microwave synthesis connects with the (quantum) dots 2Health News:Tsunami in the brain 2Health News:Tsunami in the brain 3
The CA-500 series quickly and accurately measures up to 5 coagulation parameters. It is the analyzer of choice for low to mid volume laboratories, or as a backup to larger coagulation analyzers....
... is our top-of-the-line device. The ... of the Qwik-Let® Elite, in ... feature. The Lan-X technology allows ... in the removal and disposal ...
... The new Finnpipette Focus from Thermo ... with uncompromising performance. Advanced features such ... .01ul fine volume adjustment on microvolumes help ... in single channel pipettes. The new interchangeable ...
... Digital offers improved ergonomics for today's ... modified grippy finger rest and the ... and efficiency. Finnpipette Digitals also feature ... mechanism (pat. pend.) and super blow-out ...
Medicine Products: